Loading article…
Senators urge Synapse’s VC backers and partners to restore frozen customer funds, citing $65‑$96 million shortfall and BaaS oversight failures.
The Senate banking committee on Monday sent a letter to Synapse’s CEO and its venture‑capital backers demanding that customers regain access to their money after the fintech’s mid‑May bankruptcy left between $65 million and $96 million in disputed funds frozen in “for‑benefit‑of” (FBO) accounts [2].
| At a glance | |
|---|---|
| Fund shortfall | $65 M – $96 M |
| Bankruptcy date | Mid‑May 2024 |
| Key partner | Evolve Bank & Trust |
| Catalyst | Senate letter accusing VC investors and partners of mis‑leading customers |
Senators Sherrod Brown, Ron Wyden, Tammy Baldwin and John Fetterman signed the letter, which was also sent to W. Scott Stafford, president of Evolve Bank & Trust, the primary bank handling Synapse’s FBO accounts [4]. The lawmakers placed “nearly equal blame” on Synapse’s venture‑capital investors for portraying the startup as a safe alternative to traditional banks, despite the company’s failure to keep accurate sub‑ledger records [2].
Synapse’s collapse exposed a systemic risk in the Banking‑as‑a‑Service (BaaS) model, where fintechs rely on partner banks to hold consumer funds while the fintech manages accounting. In Synapse’s case, funds were spread across three banks but recorded in commingled FBO accounts, violating FDIC rules that require customer money to be held in individually named accounts [2]. The discrepancy amounted to roughly $85 million less on the banks’ books than Synapse’s internal records showed, prompting accusations that Synapse mixed consumer deposits with operating cash to stay afloat after losing its largest client, Mercury [2].
Because the missing funds were held in FBO accounts, they are ineligible for FDIC insurance, leaving customers without a safety net. With Synapse now bankrupt, there is no money to hire a forensic accounting firm to untangle the sub‑ledger errors, and the FDIC has yet to determine who, if anyone, will cover the shortfall [2]. The senators argue that banks, not fintechs, must bear ultimate responsibility for protecting consumer deposits under existing regulations [2].
The Senate’s demand underscores growing political pressure on venture‑capital firms to ensure their portfolio companies meet banking compliance standards, a question that will shape the future of fintech‑driven financial services and the broader crypto‑related BaaS ecosystem.
Coverage is mostly measured — 8 of 8 reports stay neutral.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe
AI-assisted synthesis by the TrendWatcher Editorial Desk · sourced from 4 outlets · Jun 18, 2026 · How we report
A report by trustee Jelena McWilliams indicates an $85 million discrepancy between the $265 million in customer balances and the $180 million held by partner banks, but the exact source of the missing funds is still unknown.
More than 100,000 customers of various fintech companies that used Synapse have been locked out of their savings accounts.
The trial showed consistent signals of benefit in functional endpoints, including improved hand grip strength and motor function, with effects persisting up to seven days after treatment ended.
Ignaseclant was reported as well tolerated, with all adverse events classified as mild or moderate and no serious adverse events or discontinuations.
NMD Pharma plans to conduct larger and longer-term studies to further evaluate ignaseclant’s efficacy and safety in Charcot‑Marie‑Tooth disease.